Inept digital interaction undermining pharma with clinicians
More than half of clinicians polled about digital pharma communications have said they tend to be over-promotional and not helpful.
Newsletters and Deep Dive digital magazine
More than half of clinicians polled about digital pharma communications have said they tend to be over-promotional and not helpful.
Novo Nordisk has been criticised by the FDA for a TV ad for the Wegovy pill, which the agency claims makes "false and misleading" claims.
The FDA won't accept Moderna's filing for an mRNA-based flu vaccine, in the latest signal of the changing regulatory climate for vaccines in the US.
The FDA has started a priority review of Takeda's oveporexton for sleep disorder narcolepsy, setting up a decision in the third quarter of the year.
AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron.
Editor's Picks
Newsletters and Deep Dive
digital magazine